1. Current Therapy for Hypercholesterolemia
2. Treatment of hyperlipidaemia
3. , , , , , and , Hypolipoproteinemic activity of XU 62-320, a potent competitive inhibitor of HMG-CoA reductase, Eighth International Symposium on Atherosclerosis, Rome, October 9–13, 1988, p. 230.
4. , , , , , , , , and , XU 62–320, an HMG-CoA reductase inhibitor, more potent than compactin and lovastatin, Eighth International Symposium on Atherosclerosis, Rome, October 9–13, 1988, p. 445.
5. Disposition of fluvastatin, an inhibitor of HMG-CoA reductase, in mouse, rat, dog, and monkey